Skip to content

Medical emergency? What to do

Statin label to carry diabetes warning

3-RXPublished February 29, 20122 min read

Key points

  • All statin labels will now include a warning about a small increased risk for elevated blood glucose levels and possible problems with transient memory and cognition, the FDA announced today.
  • Now clinicians need only perform liver enzyme tests before starting statin therapy and if a patient presents with symptoms of liver problems, including: unusual fatigue or weakness; loss of appetite; upper belly pain; dark-colored urine; yellowing of the skin or the whites of the eyes.
  • The new diabetes warning comes after hyperglycemia was observed in a substudy of the PROVE-IT TIMI 22 clinical trial in which researchers noted elevated blood glucose levels among patients treated with 40-mg atorvastatin.
  • In addition to these changes, the FDA has also modified labeling information for lovastatin (Mevacor), including a warning about the increased risk for myopathy and rhabdomylosis, and added a list of 10 contraindicated drugs or drug classes.

All statin labels will now include a warning about a small increased risk for elevated blood glucose levels and possible problems with transient memory and cognition, the FDA announced today.

The agency will also remove existing recommendations to perform routine liver function tests on all patients taking the cholesterol-lowering medications, after concluding, “serious liver injury with statin use is rare and unpredicatable.”

“We want health care professionals and patients to have the most current information on the risks of statins, but also to assure them that these medications continue to provide an important health benefit of lowering cholesterol,” Mary Parks, MD, of the FDA's Center for Drug Evaluation and Research, said in a press release.

Now clinicians need only perform liver enzyme tests before starting statin therapy and if a patient presents with symptoms of liver problems, including: unusual fatigue or weakness; loss of appetite; upper belly pain; dark-colored urine; yellowing of the skin or the whites of the eyes.

The labeling changes apply to atorvastatin (Lipitor), fluvastatin (Lescol), lovastatin (Mevacor), lovastatin extended-release (Altoprev), pitavastatin (Livalo), pravastatin (Pravachol), rosuvastatin (Crestor), and simvastatin (Zocor).

The new diabetes warning comes after hyperglycemia was observed in a substudy of the PROVE-IT TIMI 22 clinical trial in which researchers noted elevated blood glucose levels among patients treated with 40-mg atorvastatin. Additional data from a meta-analysis of 13 statin trials "reported that statin therapy was associated with a 9% increased risk for incident diabetes."

Evidence to support the loss of memory and cognition with statins is less well defined and consists mostly of information from post-marketing adverse event reporting, according to the FDA. Most statin-associated memory impairment is reversible when the medication is discontinued.

In addition to these changes, the FDA has also modified labeling information for lovastatin (Mevacor), including a warning about the increased risk for myopathy and rhabdomylosis, and added a list of 10 contraindicated drugs or drug classes. These drugs include: itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir and nefazodone.

###

Nicole Blazek

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug Abuse
Drug Abuse

Study raises caution on new painkillers

A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests. The experiments with rat brain found that the TRPV1 receptor…

4 min read

Cancer

Cancer pill could affect women's fertility - report

Long-term use of the cancer pill Gleevec may produce fertility problems in women, Greek doctors reported on Wednesday. Chemotherapy and radiation have long been known to damage the fertility of patients, but little…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.